People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Biotech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zivo Bioscience, Inc. | — | Biotech | Series A | $14.6M | $34.1M | 2023 |
| Generex Biotechnology Corp | — | Pharmaceuticals | Seed | $4.8M | $72.5M | 2012 |
Nola E. Masterson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nola E. Masterson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Anderson | 1 | 8 |
| JOHN PAYNE | 1 | 7 |
| John Gorman | 1 | 7 |
| Mark Corrao | 1 | 6 |
| Craig Eagle | 1 | 4 |
| BRIAN YOUNG | 1 | 3 |
| Peter Vitulli | 1 | 3 |
| Terry Thompson | 1 | 3 |
| John B. Payne | 1 | 3 |
| Brian McGee | 1 | 3 |
| Howard Baer | 1 | 2 |
| THOMAS COX | 1 | 2 |
| Andrew Dahl | 1 | 2 |
| Keith R. Marchiando | 1 | 2 |
| Andrew A Dahl | 1 | 2 |
| Nola Masterson | 1 | 2 |
| Mark A. Fletcher | 1 | 2 |
| Richard Purcell | 1 | 2 |
| CHRIS MAGGIORE | 1 | 1 |
| David H. Brusegard, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.